MENU
+Compare
KPTI
Stock ticker: NASDAQ
AS OF
Nov 25, 04:59 PM (EDT)
Price
$5.50
Change
-$0.06 (-1.08%)
Capitalization
94.97M

KPTI Karyopharm Therapeutics Inc. Forecast, Technical & Fundamental Analysis

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases... Show more

Industry: #Biotechnology
KPTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for KPTI with price predictions
Nov 24, 2025

KPTI sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for KPTI moved above the 200-day moving average on October 21, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 18, 2025. You may want to consider a long position or call options on KPTI as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KPTI just turned positive on November 17, 2025. Looking at past instances where KPTI's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KPTI advanced for three days, in of 242 cases, the price rose further within the following month. The odds of a continued upward trend are .

KPTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 50 cases where KPTI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

KPTI moved below its 50-day moving average on November 19, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KPTI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (27.722). P/E Ratio (0.000) is within average values for comparable stocks, (51.664). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.908). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (0.335) is also within normal values, averaging (322.739).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. KPTI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KPTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
KPTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
85 Wells Avenue
Phone
+1 617 658-0600
Employees
325
Web
https://www.karyopharm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HNOI0.400.10
+32.28%
HNO International Inc.
NASC0.02N/A
+20.13%
Nascent Pharma Holdings Inc.
VDMCY8.120.22
+2.78%
Vodacom Group Ltd.
CNDCF9.85N/A
N/A
Canadian Banc Corp
JSGCF12.00N/A
N/A
LIXIL Corp.

KPTI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KPTI has been loosely correlated with XENE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if KPTI jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPTI
1D Price
Change %
KPTI100%
-5.59%
XENE - KPTI
37%
Loosely correlated
+2.16%
PGEN - KPTI
36%
Loosely correlated
-1.55%
MGNX - KPTI
36%
Loosely correlated
+1.43%
ARRY - KPTI
35%
Loosely correlated
-1.05%
OCGN - KPTI
33%
Loosely correlated
+2.16%
More